home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650084.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
1KB
|
23 lines
Document 0084
DOCN M9650084
TI HIV and intermediate immune deficiency.
DT 9605
AU Adelstein S; McKnight I; Pethebridge AM; Department of Clinical
Immunology, Royal Prince Alfred Hospital,; Sydney, NSW.
SO Med J Aust. 1996 Jan 15;164(2):109-10. Unique Identifier : AIDSLINE
MED/96158829
AB Intermediate immune deficiency is defined by a CD4 cell count between
500/microL and 200/microL. This phase is one of increasing therapeutic
intervention, mostly for minor infections of skin and mucous membranes
and mostly manageable within general practice. Most people with HIV
begin antiretroviral therapy during this phase. Regular monitoring of
CD4 cell count is essential for making appropriate therapeutic decisions
and for determining prognosis.
DE Adult Antiviral Agents/THERAPEUTIC USE *Clinical Medicine CD4
Lymphocyte Count Human HIV Infections/IMMUNOLOGY/*THERAPY Middle Age
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).